VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
t(11;16)(q23;p13)/KMT2A-CREBBP in hematologic malignancies: presumptive evidence of myelodysplasia or therapy-related neoplasm?
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
t(11;16)(q23;p13)/KMT2A-CREBBP in hematologic malignancies: presumptive evidence of myelodysplasia or therapy-related neoplasm?
t(11;16)(q23;p13)/KMT2A-CREBBP in hematologic malignancies: presumptive evidence of myelodysplasia or therapy-related neoplasm? Ann Hematol. 2020 Mar; 99(3):487-500.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Chromosomes, Human, Pair 11
Chromosomes, Human, Pair 16
CREB-Binding Protein
Databases, Factual
Female
Hematologic Neoplasms
Histone-Lysine N-Methyltransferase
Humans
Leukemia, Myeloid, Acute
Male
Middle Aged
Myelodysplastic Syndromes
Myeloid-Lymphoid Leukemia Protein
Neoplasms, Second Primary
Oncogene Proteins, Fusion
Risk Assessment
Topoisomerase II Inhibitors
Translocation, Genetic
authors with profiles
CARLOS E BUESO-RAMOS
GUILLERMO GARCIA-MANERO
SANAM LOGHAVI
L JEFFREY MEDEIROS
HAGOP M KANTARJIAN